60070-04-4

Basic information

• Product Name: Benzene, 1,2-bis(bromomethyl)-4-(1,1-dimethylethyl)-
• Synonyms: 1-tert-butyl-3,4-dibromomethylbenzene;3,4-bis(bromomethyl)-tert-butylbenzene;Benzene,1,2-bis(bromomethyl)-4-(1,1-dimethylethyl)
• CAS NO: 60070-04-4
• Molecular Formula: C12H16Br2
• Molecular Weight: 320.067
• Mol File: 60070-04-4.mol

Chemical Properties

• CAS DataBase Reference: Benzene, 1,2-bis(bromomethyl)-4-(1,1-dimethylethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,2-bis(bromomethyl)-4-(1,1-dimethylethyl)-(60070-04-4)
• EPA Substance Registry System: Benzene, 1,2-bis(bromomethyl)-4-(1,1-dimethylethyl)-(60070-04-4)

Safety Data

• Hazardous Substances Data: 60070-04-4(Hazardous Substances Data)

Upstream product

• 7397-06-0 4-t-butyl-o-xylene 
• 95-47-6 o-xylene 
• 32703-79-0 4-tert-butylphthalic anhydride 
• 374592-80-0 4-(tert-butyl)benzene-1,2-dimethanol 

Downstream Products

• 130817-07-1 exo-6-tert-butyl-1,4-epithio-N-phenyl-1,2,3,4-tetrahydronaphthalene-2,3-dicarboximide 
• 130817-07-1 endo-6-tert-butyl-1,4-epithio-N-phenyl-1,2,3,4-tetrahydronaphthalene-2,3-dicarboximide 

Relevant articles and documents

Poly(5-tert-butyl)benzothiophene: A soluble form of polyisothianaphthene with a large nonlinear optical response

A soluble form of polybenzothiophene has been produced and chemically characterised. NMR spectroscopy indicates that there is a large quinoidal character contribution to the ground state of the polymer. The third order nonlinear optical properties of the

IDO/TDO Inhibitor

A compound of formula (I) given below or a pharmaceutically acceptable salt of the compound is useful as an IDO/TDO inhibitor. Thus, the compound of formula (I) or the pharmaceutically acceptable salt of the compound can be used as, for example, a therapeutic agent for a disease or a disorder selected from tumor, infectious disease, neurodegenerative disorder, cataract, organ transplant rejection, autoimmune disease, postoperative cognitive impairment, and disease related to women's reproductive health [in the following formula (I), ring A represents an aromatic ring, an aliphatic ring, a heterocyclic ring, or a condensed ring of two or more rings selected from an aromatic ring, an aliphatic ring and a heterocyclic ring; X, R1 and R2 represent a substituent on a ring atom constituting ring A; m represents an integer of 0 to 6; X represents, for example, a halogen atom; and R1 and R2 are the same or different and are selected from, for example, the group consisting of groups of formula (a) or formula (b); and in the following formula (a) and formula (b), Y is selected from the group consisting of O, S, and Se, Z is selected from the group consisting of O, S, and Se, n represents an integer of 1 to 8, r represents an integer of 1 to 8, s represents an integer of 1 to 8, R4 represents, for example, —C(═NH)—HN2, and R6 represents, for example, a substituted or unsubstituted aryl group].

Conformational analysis and selection of odor-active conformers: Synthesis of molecules designed for the lily-of-the-valley(Muguet)-type odor

The selection of odor-active conformers and the construction of a model for a targeted odor type, i.e., for the lily-of-the-valley odor, were examined. The disagreement of the odors of 1,3,4,5-tetrahydro-2-benzoxepin derivative 1 and 3-[4-(tert-butyl)phen

Antiviral agent containing benzodithiin derivative as active ingredient

Antiviral agents comprising, as an active ingredient, a 1,4-dihydro-2,3-benzodithiin derivative of the formula STR1 wherein each symbol is as defined in the Specification, or a pharmacologically acceptable salt thereof. The antiviral agents of the present invention have superior antiviral activity and are effective for the preventive and therapeutic treatment of viral diseases caused typically by RS virus.